Valor Equity Partners β 2024 Investments
4 investments dated 2024 Β· listed companies and verified rows first Β· show all
BiotechChicago, US
Darien Parhad(Executive Officer)Patrick Morris(Executive Officer, Director)Sai Chavala(Director)
BoardTimothy Cunniff(Director)Jeffrey Aronin(Director)
Board seatAntonio GraciasΒ· per SEC Form D Β· $250K raise Β· filed Oct 2024
Holobiome discovers and develops therapies derived from the human gut microbiome, working to translate microbiome science into probiotics and targeted treatments for whole-body health.
AI & Machine LearningBiotechHealthtechLongevityBoston, US
Philip Strandwitz(Co-founder & Director, Chief Executive Officer)inKim Lewis(Co-founder, Director)Mike La Fleur(President, Co-founder, Director)Michael LaFleur(Executive Officer)
BoardJoan LaRovere(Director)inIain Chessell(Director)
Co-investorsAble PartnersBantam GroupHealthtech CapitaliSelect FundPace VenturesAlexandria+3 more
Valor Vision provides movement analysis software for sports teams and athletes, using video and kinematic data to assess joint range-of-motion, functional movements, and performance mechanics for injury prevention and rehabilitation.
AI & Machine LearningDigital HealthHealthtechSports TechAustin, US
Co-investorsTechstarsAndreessen HorowitzFounders FundSequoia CapitalVy Capital
WEKA develops a high-performance data infrastructure platform designed for AI and HPC workloads, offering storage and compute management across edge, core, and cloud environments.
AI & Machine LearningCloud ComputingData & Infrastructure
Liran Zvibel(Founder)in
Co-investors10DHitachi VenturesKey1 CapitalLumir VenturesNorwest Venture PartnersQualcomm Ventures+6 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.